Modeling Polyzwitterion-Based Drug Delivery Platforms: A Perspective of the Current State-of-the-Art and Beyond.
Journal
ACS engineering AuDOI
10.1021/acsengineeringau.2c00008PubMed ID
35996394Item Type
ArticleLanguage
enEISSN
2694-2488ae974a485f413a2113503eed53cd6c53
10.1021/acsengineeringau.2c00008
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as © 2022 The Authors. Published by American Chemical Society.
Related articles
- Novel zwitterionic vectors: Multi-functional delivery systems for therapeutic genes and drugs.
- Authors: Zhou LY, Zhu YH, Wang XY, Shen C, Wei XW, Xu T, He ZY
- Issue date: 2020
- Recent advances on next generation of polyzwitterion-based nano-vectors for targeted drug delivery.
- Authors: Qian H, Wang K, Lv M, Zhao C, Wang H, Wen S, Huang D, Chen W, Zhong Y
- Issue date: 2022 Mar
- Zwitterionic drug nanocarriers: a biomimetic strategy for drug delivery.
- Authors: Jin Q, Chen Y, Wang Y, Ji J
- Issue date: 2014 Dec 1
- pH-responsive zwitterionic polypeptide as a platform for anti-tumor drug delivery.
- Authors: Liu N, Han J, Zhang X, Yang Y, Liu Y, Wang Y, Wu G
- Issue date: 2016 Sep 1
- Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
- Authors: Foffi G, Pastore A, Piazza F, Temussi PA
- Issue date: 2013 Aug